Cengiz Demir

Dr. Cengiz Demir

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2015 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
HEHalil Er
Halil Er
MAMustafa Altindi̇ş
Mustafa Altindi̇ş
GAGülşah Aşik
Gülşah Aşik
CDCengiz Demir
Cengiz Demir
<%=header_description %> <%=header_description %>

1 January 2015 in Türk Mikrobiyoloji Cemiyeti Dergisi
Verified
Journal Article
Closed access
HEHalil Er
Halil Er
GAGülşah Aşik
Gülşah Aşik
ÖYÖzlem Yoldaş
Özlem Yoldaş
CDCengiz Demir
Cengiz Demir
RKRecep Keşli̇
Recep Keşli̇

15 January 2018 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
CDCengiz Demir
Cengiz Demir
RKRecep Keşli̇
Recep Keşli̇
The aim of this study was to identify gram-negative anaerobic bacilli isolated from various clinical specimens that were obtained from patients with suspected anaerobic infections and to determine the antibiotic resistance profiles by using the antibiotic concentration gradient method. The study was performed in Afyon Kocatepe University Ahmet Necdet Sezer Research and Practice Hospital, Medical Microbiology Laboratory between 1 November 2014 and 30 October 2015. Two hundred and seventyeight clinical specimens accepted for anaerobic culture were enrolled in the study. All the samples were cultivated anaerobically by using Schaedler agar with 5% defibrinated sheep blood and Schaedler broth. The isolated anaerobic gram-negative bacilli were identified by using both the conventional methods and automated identification system (VITEK 2, bioMerieux, France). Antibiotic susceptibility tests were performed with antibiotic concentration gradient method (E-test, bioMerieux, France); against penicillin G, clindamycin, cefoxitin, metronidazole, moxifloxacin, imipenem, meropenem, ertapenem and doripenem for each isolate. Of the 28 isolated anaerobic gram-negative bacilli; 14 were identified as Bacteroides fragilis group, 9 were Prevotella spp., and 5 were Fusobacterium spp. The highest resistance rate was found against penicillin (78.5%) and resistance rates against clindamycin and cefoxitin were found as 17.8% and 21.4%, respectively. No resistance was found against metronidazole, moxifloxacin, imipenem, meropenem, ertapenem and doripenem. As a result, isolation and identification of anaerobic bacteria are difficult, time-consuming and more expensive when compared with the cost of aerobic culture. The rate of anaerobic bacteria isolation may be increased by obtaining the appropriate clinical specimen and appropriate transportation of these specimens. We believe that the data obtained from the study in our center may offer benefits for the follow up and treatment of infections caused by anaerobic bacteria and may contribute to the current literature. Because of high resistance rate detected against penicillin, this antibiotic should not be used as a first choice in empirical treatment. Cefoxitin may be used in empirical antimicrobial treatment of anaerobic gram-negatives; but the rate of antibiotic resistance should be detected for more useful and proper treatment. The prior selection of the most effective antibiotic, may contribute to decrease the rate of high resistance. In our study, no resistance was observed against carbapenem group antibiotics and metronidazole; so these antibiotics should be reserved as treatment options in the future for infections caused by resistant gram-negative anaerobic bacteria.

31 August 2024 in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
Verified
Journal Article
Closed access
MGMelahat Gürbüz
Melahat Gürbüz
CDCengiz Demir
Cengiz Demir
SÜSelahattin Ünlü
Selahattin Ünlü
BYBetül Fatmanur Yıldırım
Betül Fatmanur Yıldırım
YÇYeliz Çetinkol
Yeliz Çetinkol
Objective: Hepatitis C virus (HCV) is a single-stranded, positive-sense RNA virus belonging to the genus Hepacivirus in the Flaviviridae family. It has eight known genotypes and 93 subtypes. HCV can be transmitted through various routes, including blood transfusion, surgical procedures, sexual contact, and intravenous drug use, leading to both acute and chronic hepatitis. Genotype (GT) determination and viral load assessment are essential for selecting an appropriate antiviral treatment regimen and duration, and for monitoring treatment efficacy. We aimed to ascertain the genotype distribution over a three-year period. Methods: In this study, patients diagnosed with chronic HCV infection and followed at Afyonkarahisar Health Sciences University Health Practice and Research Hospital between July 1, 2020, and June 30, 2023, were retrospectively evaluated for their age, gender, and HCV genotype data. Results: A total of 91 patients’ HCV genotype data were included in the study. The study revealed that 95.6% of the patients were Turkish citizens, while 4.4% were of foreign nationality. Among the 91 patients, 60 (65.9%) were found to have genotype 1b, 12 (13.2%) had genotype 1a, 10 (11%) had genotype 3, 6 (6.6%) had genotype 4, 2 (2.2%) had genotype 2, and one patient (1.1%) had a co-infection of genotypes 3 and 4. Conclusion: Genotype 1b was dominant in our region. Identifying HCV genotypes is important in guiding the prognosis and treatment of chronic HCV infections and monitoring the epidemiologic changes. This information will be of great value in the health policy that targets HCV and in elimination efforts.

28 April 2025 in LLM Dergi
Verified
Journal Article
Closed access
CDCengiz Demir
Cengiz Demir
GSGuldane Cengiz Seval
Guldane Cengiz Seval
MYMeltem Kurt Yüksel
Meltem Kurt Yüksel
PTPervin Topçuoğlu
Pervin Topçuoğlu
ÖAÖnder Arslan
Önder Arslan
STSelami Koçak Toprak
Selami Koçak Toprak

20 October 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
MŞMerih Şimşek
Merih Şimşek
CDCengiz Demir
Cengiz Demir
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a global health threat driven by limited treatment options and high-risk clones. This study aimed to characterise the clonal structure, resistance and virulence determinants and carbapenemase-carrying genetic elements of CRKP isolates from a tertiary-care hospital in Türkiye. Twenty-five isolates, one per patient, were collected between October 2023 and October 2024, tested against EUCAST criteria and sequenced with Oxford Nanopore long reads. Analyses comprised MLST, 2335-locus cgMLST, resistome, virulome, plasmid (MOB-suite), pan-genome (Panaroo) and defence-system profiling. All isolates were carbapenem-resistant, 19 ceftazidime-avibactam-resistant and seven colistin-resistant. Six sequence types and five genetic clusters were identified, with ST147 predominant (n = 13). The commonest carbapenemase profile was blaNDM-5 plus blaOXA-48 (n = 13), followed by blaKPC-3 alone (n = 5) and blaNDM-7 alone (n = 2). blaNDM-5 and blaOXA-48 were mainly carried by conjugative plasmids pAA405 and pAA002, whereas four isolates carried carbapenemases on chromosome-associated or IncX3 elements. blaNDM-5 co-occurred with the aerobactin operon in 15 isolates. The pan-genome comprised 7377 gene clusters, and isolates within a genetic cluster differed phenotypically and genotypically. Resistance and virulence determinants converged within ST147 and on shared plasmids, so genomic surveillance should consider genetic cluster, element architecture and accessory genome together.